T2 Biosystems Reinforces Market Position With Extended Vizient Agreement
Inovio Pharmaceuticals: A Strong Buy on Promising IL-12 Therapy Developments and Market Interest
Ford, Envista Holdings, and Alaska Air Are Among Additions to GS' Short Duration List
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading lower by 33.9% to $0.22 Thursday afternoon after the company announced the pricing of a $4.4 million registered direct offering.Toni
Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why
Xilio Therapeutics Inc (NASDAQ:XLO) shares are surging as the company announced an exclusive license agreement with Gilead Sciences Inc (NASDAQ:GILD) to develop and commercialize Xilio's Phase 1 tumor
Viatris Price Target Raised to $13.00/Share From $11.00 by Piper Sandler
Viatris Price Target Raised to $13.00/Share From $11.00 by Piper Sandler